Insider trading

Period: 120 months Stock: EOLS + Add filter Clear all

Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in

When Periodin use

Who Role

The trade Type of trade Minimum amount Plan Share of their own holding

Ownership What the chief executive holds

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months

140 decisions over 120 months

Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners

140 decisions over 120 months

The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any140 Buys47 Sells93 Cluster buys

140 decisions over 120 months

The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more

140 decisions over 120 months

The trade

Plan

Discretionary: they chose to sell that week.
Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.

Any Discretionary Scheduled (10b5-1) Not stated Not on a plan

140 decisions over 120 months

The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

140 decisions over 120 months

Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

140 decisions over 120 months

Stock

Insider

Type ?

Of own stake ↓

Why it stands out

EOLS Evolus, Inc.

12 Aug 2021

Medytox Inc. 10% owner

Bought

$427.71K 39,126 at 10.93

0.6%

Largest buy in 3 yrs

EOLS Evolus, Inc.

12 Aug 2021

Medytox Inc. 10% owner · indirect

Bought

$252.77K 23,000 at 10.99

0.3%

EOLS Evolus, Inc.

11 Aug 2021

Medytox Inc. 10% owner

Bought

$281.74K 26,160 at 10.77

0.4%

First buy on file

EOLS Evolus, Inc.

10 Aug 2021

MOATAZEDI DAVID See Remarks

Bought

$466.84K 41,763 at 11.18

8.5%

First buy on file

EOLS Evolus, Inc.

10 Aug 2021

Avelar Rui See Remarks

Sold, plan not stated

$159.79K 14,293 at 11.18

6.4%

EOLS Evolus, Inc.

10 Aug 2021

SILVERNAIL LAUREN P See Remarks

Bought

$159.77K 14,293 at 11.18

7.9%

First buy on file

EOLS Evolus, Inc.

10 Aug 2021

Muilenburg Crystal Chief Marketing Officer

Bought

$59.94K 5,362 at 11.18

5.6%

First buy on file

EOLS Evolus, Inc.

25 Jan 2021

MOATAZEDI DAVID See Remarks

Sold, plan not stated

$61.99K 8,310 at 7.46

4.6%

EOLS Evolus, Inc.

25 Jan 2021

SILVERNAIL LAUREN P See Remarks

Sold, plan not stated

$20.13K 2,699 at 7.46

2.9%

EOLS Evolus, Inc.

25 Jan 2021

Jafar Michael M. See Remarks

Sold, plan not stated

$20.13K 2,699 at 7.46

1.5%

EOLS Evolus, Inc.

25 Jan 2021

Avelar Rui See Remarks

Sold, plan not stated

$20.13K 2,699 at 7.46

2.0%

EOLS Evolus, Inc.

7 Jan 2020

Avelar Rui See Remarks

Sold, plan not stated

$422.28K 39,442 at 10.71

35.8%

EOLS Evolus, Inc.

13 Jun 2019

GILL DAVID N Director

Bought

$27.30K 2,000 at 13.65

66.7%

First buy on file

EOLS Evolus, Inc.

3 Jun 2019

Malik Vikram Director · indirect

Bought

$25.00M 1,298,701 at 19.25

opened

First buy on file

EOLS Evolus, Inc.

3 Jun 2019

AEON Biopharma, Inc. 10% owner

Sold, plan not stated

$25.00M 1,298,701 at 19.25

13.0%

EOLS Evolus, Inc.

31 May 2019

SILVERNAIL LAUREN P See Remarks

Sold, plan not stated

$35.35K 2,612 at 13.53

8.7%

EOLS Evolus, Inc.

29 May 2019

Romine Kristine Director · indirect

Bought

$30.86K 2,090 at 14.77

154%

First buy on file

EOLS Evolus, Inc.

22 May 2019

AEON Biopharma, Inc. 10% owner

Sold, plan not stated

$5.59M 290,518 at 19.25

2.8%

EOLS Evolus, Inc.

20 May 2019

AEON Biopharma, Inc. 10% owner

Sold, plan not stated 2×

$96.59M 5,017,422 at 19.25

32.9%

EOLS Evolus, Inc.

20 May 2019

BLANK SIMONE Director · indirect

Bought

$12.10M 628,536 at 19.25

213%

First buy on file

EOLS Evolus, Inc.

20 May 2019

Romine Kristine Director

Bought

$780.82K 40,562 at 19.25

101%

First buy on file

EOLS Evolus, Inc.

17 Dec 2018

Malik Vikram Director

Bought

$101.69K 7,800 at 13.04

90.7%

First buy on file

EOLS Evolus, Inc.

17 Dec 2018

Romine Kristine Director

Bought

$63.75K 5,000 at 12.75

14.1%

First buy on file

EOLS Evolus, Inc.

14 Dec 2018

Romine Kristine Director

Bought

$137.45K 11,000 at 12.50

45.2%

First buy on file

EOLS Evolus, Inc.

14 Dec 2018

GILL DAVID N Director

Bought

$38.30K 3,000 at 12.77

opened

First buy on file

EOLS Evolus, Inc.

29 Nov 2018

AEON Biopharma, Inc. 10% owner

Sold, plan not stated

$8.03M 573,888 at 14.00

3.6%

EOLS Evolus, Inc.

29 Nov 2018

BLANK SIMONE Director · indirect

Bought

$4.13M 295,024 at 14.00

opened

First buy on file

EOLS Evolus, Inc.

29 Nov 2018

Romine Kristine Director

Bought

$88.86K 6,347 at 14.00

35.3%

First buy on file

EOLS Evolus, Inc.

14 Sep 2018

Jafar Michael M. Chief Marketing Officer

Bought

$266.59K 12,800 at 20.83

25.5%

First buy on file

EOLS Evolus, Inc.

11 Sep 2018

AEON Biopharma, Inc. 10% owner

Sold, plan not stated

$36.82M 1,750,000 at 21.04

9.9%

EOLS Evolus, Inc.

22 Aug 2018

Romine Kristine Director

Bought

$198.27K 10,000 at 19.83

125%

First buy on file

EOLS Evolus, Inc.

23 Jul 2018

AEON Biopharma, Inc. 10% owner

Sold, plan not stated

$18.80M 1,000,000 at 18.80

5.4%

EOLS Evolus, Inc.

14 Jun 2018

Malik Vikram Director

Bought

$248.35K 8,600 at 28.88

opened

First buy on file

EOLS Evolus, Inc.

8 Jun 2018

Romine Kristine Director

Bought

$56.10K 2,000 at 28.05

33.3%

First buy on file

EOLS Evolus, Inc.

7 Jun 2018

Romine Kristine Director · indirect

Bought

$6.68K 200 at 33.40

20.0%

First buy on file

EOLS Evolus, Inc.

6 Jun 2018

Hau Bosun Director

Bought

$101.26K 2,898 at 34.94

40.6%

First buy on file

EOLS Evolus, Inc.

4 Jun 2018

Hau Bosun Director

Bought

$208.47K 7,142 at 29.19

opened

First buy on file

EOLS Evolus, Inc.

1 Jun 2018

Romine Kristine Director

Bought

$102.95K 4,000 at 25.74

200%

First buy on file

EOLS Evolus, Inc.

31 May 2018

Romine Kristine Director

Bought

$48.80K 2,000 at 24.40

opened

First buy on file

EOLS Evolus, Inc.

31 May 2018

Romine Kristine Director · indirect

Bought

$24.40K 1,000 at 24.40

100%

First buy on file

Showing 101–140 of 140.